Robert Iannone, EVP, Global Head of R&D & CMO: Jazz Pharmaceuticals JAZZ Sell · Filed 25/03/07

Trade details

Type: Insider sale
Amount: $764,577.72
Shares · price: 5,532 sh · $138.21 a share
Held after: 83,572 sh
Stock: Jazz Pharmaceuticals JAZZ
Person: Robert IannoneEVP, Global Head of R&D & CMO
Trade date: 25/03/07
Filed: 25/03/07
Days to filing: 0 days

Sold 6.2% of holdings

Share of holding sold: 6.2%

Jazz Pharmaceuticals trades, last 26 weeks

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/05~25/04/06

Robert Iannone's recent trades

Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$19.2M
76,921 sh
$19.2M
Filed 08/27
Traded 08/27
Robert IannoneEVP, Global Head of R&D & CMO
Sell10b5-1 planJazz Pharmaceuticals
Sell10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/19
Traded 25/11/17
Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/17
Traded 25/11/17
Robert IannoneEVP, Global Head of R&D & CMO
SellJazz Pharmaceuticals
Sell
Jazz Pharmaceuticals
JAZZ
$332.6K
2,403 sh
$332.6K
Filed 25/03/12
Traded 25/03/10
Robert IannoneEVP, Global Head of Research a
Planned saleJazz Pharmaceuticals
Planned sale
Jazz Pharmaceuticals
JAZZ
$256.2K
1,767 sh
$256.2K
Filed 25/03/10
Traded 25/03/10

Robert Iannone, CMO — sold $764.6K of Jazz Pharmaceuticals JAZZ · 6.2% of holdings · 10b5-1 plan | Whalegun